Orthofix Medical Inc. (NASDAQ:OFIX) Insider Aviva Mcpherron Sells 3,728 Shares

Orthofix Medical Inc. (NASDAQ:OFIX - Get Free Report) insider Aviva Mcpherron sold 3,728 shares of the business's stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $10.51, for a total transaction of $39,181.28. Following the completion of the sale, the insider now directly owns 46,322 shares in the company, valued at approximately $486,844.22. This represents a 7.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Orthofix Medical Trading Up 1.6%

OFIX stock traded up $0.17 during midday trading on Thursday, hitting $11.04. The stock had a trading volume of 421,082 shares, compared to its average volume of 283,759. The firm has a market cap of $432.55 million, a P/E ratio of -2.99 and a beta of 0.80. The company has a current ratio of 2.71, a quick ratio of 1.50 and a debt-to-equity ratio of 0.38. Orthofix Medical Inc. has a 1-year low of $10.24 and a 1-year high of $20.73. The business has a fifty day moving average price of $11.89 and a two-hundred day moving average price of $15.29.

Hedge Funds Weigh In On Orthofix Medical

Several hedge funds and other institutional investors have recently bought and sold shares of OFIX. Strs Ohio acquired a new position in shares of Orthofix Medical during the first quarter valued at about $150,000. Jane Street Group LLC acquired a new position in shares of Orthofix Medical during the first quarter valued at about $1,076,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of Orthofix Medical during the first quarter valued at about $575,000. Philosophy Capital Management LLC acquired a new position in shares of Orthofix Medical during the first quarter valued at about $6,047,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Orthofix Medical by 6.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,561 shares of the medical device company's stock valued at $335,000 after purchasing an additional 1,213 shares during the period. Institutional investors and hedge funds own 89.76% of the company's stock.

Analyst Upgrades and Downgrades

OFIX has been the topic of several analyst reports. JMP Securities reissued a "market perform" rating on shares of Orthofix Medical in a research note on Friday, June 6th. Roth Mkm reissued a "buy" rating and issued a $22.00 price objective on shares of Orthofix Medical in a research note on Wednesday, February 26th. Canaccord Genuity Group reissued a "buy" rating and issued a $24.00 price objective on shares of Orthofix Medical in a research note on Wednesday, February 26th. Barrington Research raised shares of Orthofix Medical to a "strong-buy" rating and set a $16.00 price objective on the stock in a research note on Monday. Finally, Wall Street Zen raised shares of Orthofix Medical from a "sell" rating to a "hold" rating in a research note on Saturday, June 14th. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Orthofix Medical has a consensus rating of "Moderate Buy" and an average price target of $21.50.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.